AA
NUVL

AlphaCentric Advisors’s Nuvalent NUVL Stock Holding History

AlphaCentric Advisors’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$477K Buy
4,657
+253
+6% +$25.8K 0.48% 66
2025
Q4 		$443K Buy
+4,404
New +$434K 0.44% 69
2024
Q4 		– Sell
-7,000
Closed -$716K – 264
2024
Q3 		$716K Buy
+7,000
New +$581K 0.53% 58
2023
Q2 		– Sell
-17,897
Closed -$467K – 262
2023
Q1 		$467K Buy
17,897
+2,397
+15% +$70.9K 0.32% 87
2022
Q4 		$462K Buy
+15,500
New +$432K 0.46% 74

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AlphaCentric Advisors's NUVL Position: Q1 2026 in Review

AlphaCentric Advisors increased its Nuvalent (NUVL) stake by 5.7% in Q1 2026, buying an estimated $25.8K and bringing the position to 4,657 shares worth $477K. The position accounts for 0.48% of the portfolio, ranked #66.

AlphaCentric Advisors first reported a position in NUVL in Q4 2022 and has held it in 5 quarters since. The position peaked at $716K in Q3 2024. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • AlphaCentric Advisors held 4,657 shares of Nuvalent worth $477K as of Q1 2026.
  • AlphaCentric Advisors bought 253 Nuvalent shares in Q1 2026, an estimated $25.8K.
  • Nuvalent made up 0.48% of AlphaCentric Advisors's portfolio in Q1 2026, its #66 holding.
  • AlphaCentric Advisors first reported a position in Nuvalent in Q4 2022 and has held it in 5 quarters since.
  • AlphaCentric Advisors's Nuvalent position peaked at $716K in Q3 2024.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on AlphaCentric Advisors's 13F filing for Q1 2026, filed 7 May 2026.